ArticleExperimental & molecular medicine2022

Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy.

Jing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.